Posts

Q3 2023 update: environmental sustainability related hi...

Oct 19, 2023

The global pharmaceutical industry experienced an 11% drop in new job postings r...

Q3 2023 update: social responsibility related hiring ac...

Oct 19, 2023

The global pharmaceutical industry experienced a 13% drop in new job postings re...

STAT+: Dana-Farber executive says split from Mass General will benefit patients

STAT+: Dana-Farber executive says split from Mass Gener...

Oct 18, 2023

Dana-Farber CEO Laurie Glimcher said Wednesday at the #STATSummit that the split...

STAT+: Senate Finance targets Medicare Advantage brokers

STAT+: Senate Finance targets Medicare Advantage brokers

Oct 18, 2023

Senate Finance Committee members from both parties took aim today at insurance b...

STAT+: Biotech power broker John Maraganore offers advice to the next crop of entrepreneurs

STAT+: Biotech power broker John Maraganore offers advi...

Oct 18, 2023

Since stepping down as Alnylam CEO in 2021, John Maraganore has spent much of hi...

How rising stars in science and medicine think about mentorship and bouncing back from rejection

How rising stars in science and medicine think about me...

Oct 18, 2023

"When you have a lot of rejections, the first one is the hardest, and gradually ...

Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines

Zuckerberg and Chan announce a New York biohub to build...

Oct 18, 2023

Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Prisc...

Lotte Knudsen, who pushed Novo Nordisk into the Ozempic era, wins STAT Innovation award

Lotte Knudsen, who pushed Novo Nordisk into the Ozempic...

Oct 18, 2023

Lotte Bjerre Knudsen, who persuaded Novo Nordisk to stick with GLP-1 research an...

STAT+: NIH confirmation hearing highlights just how divisive the agency’s portfolio has become

STAT+: NIH confirmation hearing highlights just how div...

Oct 18, 2023

Monica Bertagnolli, the nominee to lead the NIH, spent her confirmation hearing ...

STAT+: In drug development, large pharma companies’ staying power provides them an edge, Lilly’s chief medical officer says

STAT+: In drug development, large pharma companies’ sta...

Oct 18, 2023

In drug development, large pharma companies’ staying power provides them an edge...

STAT+: Biotech investors push to extend time before pills are subject to price negotiations

STAT+: Biotech investors push to extend time before pil...

Oct 18, 2023

Investors in biopharma companies, who lobbied vigorously — but unsuccessfully — ...

Wegovy doesn’t work for everyone, and no one’s quite sure why

Wegovy doesn’t work for everyone, and no one’s quite su...

Oct 18, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Biotech investors push to extend time before Medicare price negotiations; RiteAid closings could cause pharmacy deserts

STAT+: Pharmalittle: Biotech investors push to extend t...

Oct 18, 2023

Biopharma investors, who lobbied against allowing Medicare to negotiate drug pri...

STAT+: Why doesn’t everyone lose weight on Ozempic-type drugs? Researchers look for genetic clues

STAT+: Why doesn’t everyone lose weight on Ozempic-type...

Oct 18, 2023

Not everyone loses weight on Ozempic-type drugs. Researchers are looking for gen...

STAT+: The Ozempic panic: Why a market frenzy over new weight loss drugs defies logic

STAT+: The Ozempic panic: Why a market frenzy over new ...

Oct 18, 2023

There’s a specter haunting Wall Street: the Ozempic panic.

STAT+: In an unusual arrangement, UnitedHealth’s board chair also owns a personal investment firm

STAT+: In an unusual arrangement, UnitedHealth’s board ...

Oct 18, 2023

Hemsley, the former CEO of UnitedHealth Group and its current board chair, also ...